We are live on
!
Find out more
DMKJ
David M. Knott Jr Portfolio holdings
AUM
$168M
1-Year Est. Return
60.36%
This Fund
S&P 500
This Quarter
Est. Return
+20.24%
1 Year Est. Return
+60.36%
3 Year Est. Return
+143.93%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$216M
AUM Growth
-$32M
(-13%)
Cap. Flow
-$54.4M
Cap. Flow
% of AUM
-25.19%
Top 10 Holdings %
Top 10 Hldgs %
70.66%
Holding
99
New
11
Increased
15
Reduced
20
Closed
12
Top Buys
| 1 |
Cogent Biosciences
COGT
|
+$2.87M |
| 2 |
Alkermes
ALKS
|
+$2.27M |
| 3 |
MRSN
Mersana Therapeutics
MRSN
|
+$2.12M |
| 4 |
TG Therapeutics
TGTX
|
+$1.47M |
| 5 |
Biohaven
BHVN
|
+$1.37M |
Top Sells
| 1 |
Janus Henderson AAA CLO ETF
JAAA
|
+$17.4M |
| 2 |
Calumet Specialty Products
CLMT
|
+$11.7M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$5.96M |
| 4 |
AVDL
Avadel Pharmaceuticals
AVDL
|
+$5.54M |
| 5 |
VRNA
Verona Pharma
VRNA
|
+$4.09M |
Sector Composition
| 1 | Healthcare | 41.34% |
| 2 | Materials | 20.5% |
| 3 | Financials | 18.92% |
| 4 | Communication Services | 13.33% |
| 5 | Technology | 1.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Calumet Specialty Products
CLMT
$3.6B
| $44M | 20.38% |
2,214,969
-610,262
| -22% | -$11.7M |
|
2
Apollo Global Management
APO
$70.3B
| $32.6M | 15.08% |
225,000
| – | – |
|
|
3
Alphabet (Google) Class C
GOOG
$4.42T
| $28.7M | 13.28% |
91,420
-20,800
| -19% | -$5.96M |
|
4
Syndax Pharmaceuticals
SNDX
$2.03B
| $8.72M | 4.04% |
415,000
-13,000
| -3% | -$227K |
|
5
Xeris Biopharma Holdings
XERS
$1.51B
| $7.61M | 3.53% |
970,000
-45,000
| -4% | -$354K |
|
6
Travere Therapeutics
TVTX
$5.06B
| $7.11M | 3.29% |
186,000
-74,000
| -28% | -$2.41M |
|
7
BridgeBio Pharma
BBIO
$16B
| $6.5M | 3.01% |
85,000
| – | – |
|
8
Protagonist Therapeutics
PTGX
$8.55B
| $6.38M | 2.95% |
73,000
-10,000
| -12% | -$818K |
|
9
JPMorgan Chase
JPM
$912B
| $6.28M | 2.91% |
19,477
-897
| -4% | -$278K |
|
|
10
Janus Henderson AAA CLO ETF
JAAA
$29B
| $4.73M | 2.19% |
93,528
-344,226
| -79% | -$17.4M |
|
11
Viridian Therapeutics
VRDN
$1.98B
| $4.51M | 2.09% |
145,000
+28,426
| +24% | +$780K |
|
12
Catalyst Pharmaceutical
CPRX
| $4.41M | 2.04% |
189,000
| – | – |
|
|
13
Cogent Biosciences
COGT
$6.46B
| $3.62M | 1.68% |
+102,000
| New | +$2.87M |
|
14
Arcus Biosciences
RCUS
$3.36B
| $2.89M | 1.34% |
121,241
+26,041
| +27% | +$531K |
|
|
15
Alkermes
ALKS
$8.78B
| $2.66M | 1.23% |
95,000
+75,700
| +392% | +$2.27M |
|
16
DocGo
DCGO
$62.9M
| $2.34M | 1.09% |
2,670,850
-400,000
| -13% | -$427K |
|
|
HELP
17
Cybin Inc
HELP
$434M
| $2.33M | 1.08% |
285,182
+144,940
| +103% | +$933K |
|
18
Cytokinetics
CYTK
$11B
| $2.16M | 1% |
34,000
+4,000
| +13% | +$249K |
|
19
AtriCure
ATRC
$1.82B
| $2.03M | 0.94% |
51,400
+3,400
| +7% | +$125K |
|
20
AllianceBernstein
AB
$3.57B
| $1.85M | 0.86% |
48,000
| – | – |
|
|
ACLX
21
DELISTED
Arcellx
ACLX
| $1.68M | 0.78% |
25,700
| – | – |
|
22
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $1.59M | 0.73% |
13,000
+8,000
| +160% | +$917K |
|
|
TECX
23
Tectonic Therapeutic
TECX
$584M
| $1.54M | 0.71% |
74,000
| – | – |
|
24
Wave Life Sciences
WVE
$1.09B
| $1.53M | 0.71% |
90,000
| – | – |
|
25
Johnson & Johnson
JNJ
$601B
| $1.43M | 0.66% |
6,922
| – | – |
|
Similar funds
DI
WFS
CCG
7CM
TT
MAG
PFA
CW